The ApelinDx Inhaler delivers Thriftmaster’s proprietary formulation in controlled, metered dosage using pharmaceutical grade, FDA approved components. ApelinDx is manufactured to cGMP standards to ensure optimal quality and consistency.
Our device has undergone rigorous safety testing with the FDA in preparation for phase one clinical trials. Throughout mice model and biospecimen human cell testing, no adverse effects have been observed. As of 2024, ApelinDx has an active investigatory new drug application (Alzheimer’s) as well as active institutional review board applications (Glioblastoma, Migraines, Epilepsy). Thriftmaster continues to pursue ApelinDx’s development into an orphan drug.